224 related articles for article (PubMed ID: 23263460)
41. Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia.
Huo L; Zheng Z; Lu X; Wu F; Ning Y; Zhang XY
Front Psychiatry; 2021; 12():641278. PubMed ID: 34239458
[No Abstract] [Full Text] [Related]
42. Levels of serum S100B are associated with cognitive dysfunction in patients with type 2 diabetes.
Yu H; Li H; Liu X; Du X; Deng B
Aging (Albany NY); 2020 Feb; 12(5):4193-4203. PubMed ID: 32112645
[TBL] [Abstract][Full Text] [Related]
43. Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture.
Sun ZL; Liu J; Guo W; Jiang T; Ma C; Li WB; Tang YL; Ling SH
Psychiatry Res; 2016 Oct; 244():370-5. PubMed ID: 27525826
[TBL] [Abstract][Full Text] [Related]
44. Is BDNF biological link between depression and type 2 diabetes mellitus?
Wang J; Zhao X; He M
Med Hypotheses; 2012 Aug; 79(2):255-8. PubMed ID: 22626954
[TBL] [Abstract][Full Text] [Related]
45. High altitude with monotonous environment has significant impact on mood and cognitive performance of acclimatized lowlanders: Possible role of altered serum BDNF and plasma homocysteine level.
Das SK; Dhar P; Sharma VK; Barhwal K; Hota SK; Norboo T; Singh SB
J Affect Disord; 2018 Sep; 237():94-103. PubMed ID: 29803101
[TBL] [Abstract][Full Text] [Related]
46. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
[TBL] [Abstract][Full Text] [Related]
47. Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study.
Sanada K; de Azúa SR; Nakajima S; Alberich S; Ugarte A; Zugasti J; Vega P; Martínez-Cengotitabengoa M; González-Pinto A
Psychiatry Res; 2018 Oct; 268():1-7. PubMed ID: 29986171
[TBL] [Abstract][Full Text] [Related]
48. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance.
Fujinami A; Ohta K; Obayashi H; Fukui M; Hasegawa G; Nakamura N; Kozai H; Imai S; Ohta M
Clin Biochem; 2008 Jul; 41(10-11):812-7. PubMed ID: 18402781
[TBL] [Abstract][Full Text] [Related]
49. Serum Levels of Brain-Derived Neurotrophic Factor Are Associated with Diabetes Risk, Complications, and Obesity: a Cohort Study from Chinese Patients with Type 2 Diabetes.
Li B; Lang N; Cheng ZF
Mol Neurobiol; 2016 Oct; 53(8):5492-9. PubMed ID: 26454822
[TBL] [Abstract][Full Text] [Related]
50. Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS).
Rosa RF; Ugolini-Lopes MR; Gandara APR; Vendramini MBG; Campanholo KR; Dutra L; de Andrade DCO
Rheumatology (Oxford); 2021 Jan; 60(1):179-187. PubMed ID: 32613245
[TBL] [Abstract][Full Text] [Related]
51. Patients with type 2 diabetes exhibit cognitive impairment with changes of metabolite concentration in the left hippocampus.
Wang Y; Xu XY; Feng CH; Li YL; Ge X; Zong GL; Wang YB; Feng B; Zhang P
Metab Brain Dis; 2015 Aug; 30(4):1027-34. PubMed ID: 25875132
[TBL] [Abstract][Full Text] [Related]
52. Serum brain-derived neurotrophic factor and cognitive functioning in underweight, weight-recovered and partially weight-recovered females with anorexia nervosa.
Zwipp J; Hass J; Schober I; Geisler D; Ritschel F; Seidel M; Weiss J; Roessner V; Hellweg R; Ehrlich S
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():163-9. PubMed ID: 24859292
[TBL] [Abstract][Full Text] [Related]
53. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
[TBL] [Abstract][Full Text] [Related]
54. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
[TBL] [Abstract][Full Text] [Related]
55. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
56. Correlation analysis of monocyte chemoattractant protein-1 and clinical characteristics and cognitive impairment in type 2 diabetes mellitus comorbid major depressive disorder.
Cao F; Yang M; Cheng Y; Zhang X; Shi L; Li N
Front Aging Neurosci; 2023; 15():1081393. PubMed ID: 37213540
[TBL] [Abstract][Full Text] [Related]
57. Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls.
Zhang XY; Tang W; Xiu MH; Chen DC; Yang FD; Tan YL; Wang ZR; Zhang F; Liu J; Liu L; Chen Y; Wen N; Kosten TR
Brain Behav Immun; 2013 Aug; 32():105-11. PubMed ID: 23499732
[TBL] [Abstract][Full Text] [Related]
58. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
59. Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: evidence of a compensatory mechanism.
Arentoft A; Sweat V; Starr V; Oliver S; Hassenstab J; Bruehl H; Tirsi A; Javier E; McHugh PF; Convit A
Brain Cogn; 2009 Nov; 71(2):147-52. PubMed ID: 19481324
[TBL] [Abstract][Full Text] [Related]
60. Plasma total antioxidant status and cognitive impairments in schizophrenia.
Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
